Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 31Completed 7Recruiting 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Non-small Cell Lung Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × icotinib × Clear all
NCT06517953 2024-07-25

IcomBine

Sun Yat-sen University

Phase 2 Recruiting
23 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05104788 2021-11-03

NeoIpower

Peking University Cancer Hospital & Institute

Phase 2 Recruiting
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡